Arcellx Raises $115M in Series C Financing

23 Apr, 2021

Arcellx Raises $115M in Series C Financing
Photo by Nathan Riley on Unsplash

– Arcellx Raises $115M in Series C Financing.
– The round was co-led by Samsara BioCapital and CAM Capital, joined by new investors Adage, Asymmetry, CaaS Capital, Cambrian Bio, Sixty Degree, Soleus Capital, Surveyor Capital (a Citadel company), Suvretta, and Terra Magnum Capital Partners.
– The new investment will be used to develop CART-ddBCMA and initiate clinical trials evaluating ACLX-001 and ACLX-002 in multiple myeloma (MM) and acute myelogenous leukemia (AML) respectively.

Biopharma Health Care North America Pharmaceutical
Crunchbase icon

Content report

The following text will be sent to our editors: